This year, the Canadian Cardiovascular Congress is part of an even larger event called Vascular 2013, combining parallel conferences dedicated to cardiovascular disease, hypertension, diabetes and stroke. The University of Ottawa Heart Institute has program items in all of these—nearly 120 in all

In July, the first patient in a landmark clinical trial received treatment at the University of Ottawa Heart Institute. The new ENACT-AMI (Enhanced Angiogenic Cell Therapy—Acute Myocardial Infarction) trial, led by the Ottawa Hospital Research Institute, is designed to test whether genetically

This year, the Canadian Cardiovascular Congress (CCC) was part of an even larger event called Vascular 2013 that added parallel conferences dedicated to hypertension, diabetes and stroke. The University of Ottawa Heart Institute had program items in all of these subject areas— nearly 120 in all

The American Heart Association Scientific Sessions is the largest conference for cardiovascular science and medicine in the world. The staff of the University of Ottawa Heart Institute is once again responsible for many expert clinical talks and research presentations. This guide highlights those

Diabetes is a major contributing factor for heart disease. Diabetes patients are two to three times more likely to develop cardiovascular disease than the general population. With the condition widely undertreated and diabetes rates growing, cardiovascular professionals are looking to stem the flow

Regular physical activity is one of the most beneficial things a person can do to prevent heart disease or support their rehabilitation after a heart attack or cardiac surgery. A study recently published in the British Medical Journal found that exercise can be as good or better than drug therapy